Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

Royal recognition for novel TB test

PBD Biotech has been presented the 2019 Royal Dairy Innovation Award for their rapid Actiphage® diagnostic by HRH The Princess Royal at a special ceremony at Buckingham Palace.
  • April 18, 2019
  • Award
PBD Biotech's Berwyn Clarke, Cath Rees and Ben Swift with HRH Princess Royal
PBD Biotech's Berwyn Clarke, Cath Rees and Ben Swift with HRH Princess Royal

The innovation trophy and certificate is awarded each year by the Royal Association of British Dairy Farmers (RABDF) – for whom Princess Anne is patron – to the product which is likely to be the most significant innovation for the future of dairying.

Actiphage is a novel test to detect low levels of mycobacteria in blood and milk in just six hours. This simple technology has successfully been used in private bovine TB eradication strategies, in Johne’s disease control and also for quality assurance testing of dairy products for viable mycobacterial contamination.

Originally developed as a tool for diagnosis of human TB, Actiphage has been optimised and developed by Drs Cath Rees and Ben Swift from the University of Nottingham and the Royal Veterinary College, respectively. They received the award from Princess Anne alongside Dr Berwyn Clarke, founder and Non-Executive Director at PBD Biotech – which holds exclusive worldwide licence for Actiphage.

This is the latest in a string of awards Actiphage has been involved in, including local business awards and one of Canada’s top innovation awards for agri-tech.

Mark Hammond, PBD Biotech’s new CEO, said, “We are delighted that our technology is now able to help the dairy industry detect Mycobacteria in both livestock and dairy products worldwide and we look forward to working with dairy producers, vets and farmers in the future to help tackle these important diseases.”

Actiphage has the potential to revolutionise livestock disease management; expedite food safety checks on milk and dairy products; and ease the burden on farmers, the industry and wider public.

For more infomation, please get in touch.

Share:

Related posts

Loading...
British Farming Awards 2021 shortlist

PBD Biotech shortlisted for British Farming Awards

August 13, 2021
A new test that has the potential to eradicated bovine TB (bTB) and Johne's Disease has gained PBD Biotech a shortlisting in the Agri-Tech Innovator of the Year of the British Farming Awards.
British Farming Awards 2021 shortlist

PBD Biotech shortlisted for British Farming Awards

August 13, 2021
A new test that has the potential to eradicated bovine TB (bTB) and Johne's Disease has gained PBD Biotech a...
Mark Hammond (web)

Actiphage wins Vet Record Innovation Award 2021

February 16, 2021
Actiphage®, a rapid, accurate test for tuberculosis that detects the presence of the live mycobacteria in a sample of blood or milk, has been awarded the Innovation Award 2021 (15th February 2021) by Veterinary Record, the official journal of the...
Mark Hammond (web)

Actiphage wins Vet Record Innovation Award 2021

February 16, 2021
Actiphage®, a rapid, accurate test for tuberculosis that detects the presence of the live mycobacteria in a sample of blood...
Mark Hammond, PBD Biotech CEO

Actiphage shortlisted for Vet Record Innovation Award 2021

February 11, 2021
Actiphage, the rapid diagnostic for Bovine TB and Johne's Disease, has been short-listed for the Vet Record Innovation Award 2021. The award is for an innovation that has brought about – or has the potential to bring about – a...
Mark Hammond, PBD Biotech CEO

Actiphage shortlisted for Vet Record Innovation Award 2021

February 11, 2021
Actiphage, the rapid diagnostic for Bovine TB and Johne's Disease, has been short-listed for the Vet Record Innovation Award 2021....
PBD Biotech - Cream Awards Winners

Rapid Actiphage test for bovine TB and Johne’s wins Cream Award for Innovation

February 6, 2020
The dairy industry has presented The Cream Award for Innovation to PBD Biotech for its rapid Actiphage® test, which can detect both bovine TB and Johne’s disease infections from a single sample of blood or milk.
PBD Biotech - Cream Awards Winners

Rapid Actiphage test for bovine TB and Johne’s wins Cream Award for Innovation

February 6, 2020
The dairy industry has presented The Cream Award for Innovation to PBD Biotech for its rapid Actiphage® test, which can...
1 2 3 Next »

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More